disease progression
342 results
1 - 100
atezolizumab- ivosidenib
- entrectinib
- trametinib
- dabrafenib
- lenvatinib
- nivolumab
- larotrectinib
- abemaciclib
- cabozantinib
- acalabrutinib
- ramucirumab
- PAZOPanib
- ocrelizumab
- osimertinib
- avapritinib
- crizotinib
- pomalidomide
- ocrelizumab/hyaluronidase
- tucatinib
- lorlatinib
- alpelisib
- ripretinib
- inavolisib
- DOXOrubicin, liposomal
- copanlisib
- vemurafenib
- elacestrant
- lapatinib
- binimetinib
- bone resorption inhibitors
- cetuximab
- darolutamide
- tisotumab vedotin
- datopotamab deruxtecan
- alendronate
- ipilimumab
- venetoclax
- ibrutinib
- avelumab
- DAUNOrubicin citrate liposome
- tiludronate
- fingolimod
- ofatumumab
- teriflunomide
- nintedanib
- siponimod
- ublituximab
- glatiramer
- ribociclib
- pembrolizumab
- olaparib
- monomethyl fumarate
- dimethyl fumarate
- diroximel fumarate
- interferon gamma-1b
- enfortumab vedotin
- capivasertib
- exemestane
- bevacizumab
- sirolimus (protein bound)
- interferon beta-1a
- everolimus
- anastrozole
- interferon beta-1b
- peginterferon beta-1a
- niraparib
- fludarabine
- ado-trastuzumab
- cemiplimab
- ozanimod
- fulvestrant
- macitentan
- selexipag
- temozolomide
- belinostat
- infigratinib
- dasatinib
- SUNItinib
- axitinib
- vandetanib
- eflornithine (systemic)
- alemtuzumab
- pemigatinib
- afatinib
- trabectedin
- erdafitinib
- PEMEtrexed
- SORAfenib
- vismodegib
- rucaparib
- dacomitinib
- emapalumab
- lurbinectedin
- adagrasib